As a new type of microbial preparation, Prohep has immunological effects.

By inducing the secretion of the anti-inflammatory cytokine IL-10 and inhibiting the differentiation of intestinal Th17 cells, l Prohep prevents the occurrence of inflammation, regulates the intestinal microbiota, weakens angiogenesis in liver tumors, and subsequently inhibits tumor growth.

In the future, it could be used to prevent or treat cancer in other parts of the intestine

Laboratory tests on live animals have confirmed that Prohep is effective in the prevention and treatment of HCC.